Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
86 /100
CRITICAL RISK
Score updated Oct 13, 2026

OTLK — Outlook Therapeutics, Inc. Dilution Risk Tracker

Track OTLK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OTLK — Get alerts when the score changes →

As of October 13, 2026, Outlook Therapeutics, Inc. (OTLK) has a DilutionWatch DilutionScore of 86/100, rated CRITICAL dilution risk. Outlook Therapeutics, Inc. has a market capitalization of $142.44M, 243.45M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $5.00M, 45.29M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
57
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 62%
💰 Capital Raise model 73%
• Critical: only 2.8 months cash remaining
• Active ATM program with $5M remaining capacity
🔄 Reverse Split model est. 70%
• 50-day avg $0.28 below $1 exchange minimum
• Only 3 months cash — financial pressure
📜 Warrant Exercise model 25%
• Significant warrants: 19% of shares outstanding
🔔 Track OTLK — Get forecast alerts →

Market Data

Market Cap$142.44M
Shares Outstanding243.45M
Float105.53M
Cash$11.24M
Debt$544.97M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore86/100DilutionWatch score record
Shares Outstanding243.45MVerified float table or market cache
Public Float105.53MVerified float table or market cache
Market Cap$142.44MMarket data cache
Cash Runway2.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$5.00MSEC-derived dilution fields
Outstanding Warrants45.29MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B5 2, 8-K 2, FORM 4 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 7.12M shares
#1 Schonfeld Strategic Advisors Llc 2.44M shares
#2 Vanguard Capital Management LLC 1.97M shares
#3 Gilpin Wealth Management, LLC 600.2K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest31.90M
Days to Cover7.1
% of Float30.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-18
xbrl XBRL CONVERTIBLE 2025-12-19
Form 4 INSIDER TRANSACTION 2026-08-12
424B5 ATM 2026-04-23
8-K 8K EVENT 2026-04-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual OTLK Dilution Snapshot

Outlook Therapeutics, Inc. (OTLK) has a DilutionScore of 86/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

OTLK's DilutionScore is currently 86/100 (Critical risk), with 5 score changes tracked over 89 days. The score improved from 84/100 (Critical risk).

Period Score Risk Level Duration
Sep 17 – Oct 13, 202686/100CRITICAL27 days
Sep 03 – Sep 16, 202684/100CRITICAL14 days
Aug 22 – Sep 02, 202683/100CRITICAL12 days
Aug 14 – Aug 21, 202671/100HIGH7 days
Jul 22 – Aug 13, 202674/100HIGH23 days
Jul 16 – Jul 21, 202665/100HIGH6 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

OTLK shares outstanding have increased 15.5% from 104.61M (Mar 2026) to 120.86M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026120.86M105.53M▲ 48.86%
Mar 28, 2026104.61M70.89M▲ 4.23%
Mar 27, 2026104.61M68.01M▲ 0.41%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track OTLK Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment OTLK files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking OTLK — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OTLK
OTLK FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.